Editorial comment.
作者信息
Peters Craig A
出版信息
J Urol. 2010 Jun;183(6):2359. doi: 10.1016/j.juro.2010.02.2423. Epub 2010 Apr 18.
PMID:20400160
Abstract
摘要
相似文献
1
Editorial comment.
J Urol. 2010 Jun;183(6):2359. doi: 10.1016/j.juro.2010.02.2423. Epub 2010 Apr 18.
2
Editorial comment.
J Urol. 2010 Jun;183(6):2359. doi: 10.1016/j.juro.2010.02.2422. Epub 2010 Apr 18.
3
Reply by authors.
J Urol. 2010 Jun;183(6):2359-60. doi: 10.1016/j.juro.2010.02.2441. Epub 2010 Apr 18.
4
Urinary and serum carbohydrate antigen 19-9 as a biomarker in ureteropelvic junction obstruction in children.
J Urol. 2010 Jun;183(6):2353-60. doi: 10.1016/j.juro.2010.02.031. Epub 2010 Apr 18.
5
Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis.
Nat Med. 2006 Apr;12(4):398-400. doi: 10.1038/nm1384. Epub 2006 Mar 19.
6
Pelvi-ureteric junction obstruction in children: the role of urinary transforming growth factor-beta and epidermal growth factor.
BJU Int. 2007 Apr;99(4):899-903. doi: 10.1111/j.1464-410X.2006.06641.x.
7
Elevation of CA 19-9 in giant hydronephrosis induced by a renal calculus.
Urology. 2004 Feb;63(2):381-2. doi: 10.1016/j.urology.2003.10.048.
8
Comment on: How do we interpret an elevated carbohydrate antigen 19-9 level in asymptomatic subjects?
Dig Liver Dis. 2010 Mar;42(3):234-5. doi: 10.1016/j.dld.2009.05.020. Epub 2009 Jul 1.
9
Editorial comment.
Urology. 2009 Dec;74(6):1312; author reply 1312-3. doi: 10.1016/j.urology.2009.07.1254.
10
Editorial comment.
J Urol. 2009 Nov;182(5):2433; discussion 2434. doi: 10.1016/j.juro.2009.07.077. Epub 2009 Sep 17.
Zotero 插件